Ibrahim Alliu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ibrahim Alliu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Subash Thapa
Department of Biostatistics, Epidemiology, and Environmental Health Science, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30460, USA
5 shared publications - Lili Yu
Georgia Southern University
3 shared publications - Olamide Asifat
Department of Biostatistics, Epidemiology, and Environmental Health Science, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30460, USA
3 shared publications - Blerta Shehaj
Department of Health Policy & Community Health, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30460, USA
2 shared publications - Emmanuel U. Azu
Department of Biostatistics, Epidemiology and Environmental Science, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30458, USA
2 shared publications - Gulzar Hussain Shah
Department of Health Policy and Community Health, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA 30458, USA
2 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (20) , 3427
Long COVID and Incident Multimorbidity in the United States: Evidence from a Nationally Representative Longitudinal Study
Background/Objectives: Long COVID has been associated with elevated risks of individual chronic conditions, but its association with the transition to multimorbidity remains unclear. This study aims to examine whether retrospective COVID-19 status was associated with incident multimorbidity among U.S. adults. Methods: We analyzed Panel 24 of the Medical Expenditure Panel Survey (MEPS; 2019–2022), including 4356 individuals free of multimorbidity at baseline. COVID-19 exposure was classified as Long COVID, COVID-19-recovered, or no COVID-19. Survey-weighted logistic regression estimated associations between retrospective COVID-19 status and incident cross-domain multimorbidity, and generalized estimating equations assessed healthcare expenditures, health-related quality of life, and inpatient utilization. Results: Incident MM occurred in 106 participants: 17 with Long COVID, 41 COVID-19-recovered, and 48 with no COVID-19. In the primary model (4239 participants; 105 events), Long COVID was associated with higher odds of incident MM than no COVID-19 (OR 2.34; 95% CI, 1.14–4.79); the estimate for COVID-19-recovered participants was OR 1.71 (95% CI, 1.01–2.92). Fully adjusted and Firth estimates were directionally consistent. Cardiometabolic plus respiratory MM predominated (79/106). COVID-status-by-year interactions were not significant for total expenditures, out-of-pocket expenditures, physical or mental health scores, or inpatient stays. Conclusions: Retrospectively classified Long COVID was associated with incident cross-domain MM recorded during follow-up, but temporal ordering cannot be established, and sparse events limit precision. Replication with prospectively timed exposure and diagnosis data is needed.
- 14 October 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (20) , 3427
Open AccessLong COVID and Incident Multimorbidity in the United States: Evidence from a Nationally Representative Longitudinal Study
Background/Objectives: Long COVID has been associated with elevated risks of individual chronic conditions, but its association with the transition to multimorbidity remains unclear. This study aims to examine whether retrospective COVID-19 status was associated with incident multimorbidity among U.S. adults. Methods: We analyzed Panel 24 of the Medical Expenditure Panel Survey (MEPS; 2019–2022), including 4356 individuals free of multimorbidity at baseline. COVID-19 exposure was classified as Long COVID, COVID-19-recovered, or no COVID-19. Survey-weighted logistic regression estimated associations between retrospective COVID-19 status and incident cross-domain multimorbidity, and generalized estimating equations assessed healthcare expenditures, health-related quality of life, and inpatient utilization. Results: Incident MM occurred in 106 participants: 17 with Long COVID, 41 COVID-19-recovered, and 48 with no COVID-19. In the primary model (4239 participants; 105 events), Long COVID was associated with higher odds of incident MM than no COVID-19 (OR 2.34; 95% CI, 1.14–4.79); the estimate for COVID-19-recovered participants was OR 1.71 (95% CI, 1.01–2.92). Fully adjusted and Firth estimates were directionally consistent. Cardiometabolic plus respiratory MM predominated (79/106). COVID-status-by-year interactions were not significant for total expenditures, out-of-pocket expenditures, physical or mental health scores, or inpatient stays. Conclusions: Retrospectively classified Long COVID was associated with incident cross-domain MM recorded during follow-up, but temporal ordering cannot be established, and sparse events limit precision. Replication with prospectively timed exposure and diagnosis data is needed.
- Open Access
Interval-Censored Survival Analysis: A Comparative Monte Carlo Study of Weibull AFT and Cox Proportional Hazards Models
This study investigates the comparative performance of the Weibull accelerated failure time (AFT) model and the Cox proportional hazards (PH) model for interval-censored Weibull data. The study emphasizes baseline survival function precision and confidence interval coverage at key quantile-based time points across the survival curve. Through Monte Carlo simulation experiments and applications to the Breast Cosmesis and Diabetic Retinopathy datasets, we compare model performance using bias, empirical variance, estimated variance, and 95% coverage probability. We also evaluate two bootstrap confidence interval methods, the bias-corrected and accelerated (BCa) bootstrap and the Wald bootstrap, across the survival, log-survival, and complementary log–log scales. Results show that while both models provide reasonable regression coefficient inference, the Weibull AFT model consistently yields lower empirical variance for baseline survival estimation when the Weibull assumption holds. The complementary log–log scale provides the most stable coverage overall. These findings support the Weibull AFT model when its distributional assumption is plausible.
Open AccessInterval-Censored Survival Analysis: A Comparative Monte Carlo Study of Weibull AFT and Cox Proportional Hazards Models
This study investigates the comparative performance of the Weibull accelerated failure time (AFT) model and the Cox proportional hazards (PH) model for interval-censored Weibull data. The study emphasizes baseline survival function precision and confidence interval coverage at key quantile-based time points across the survival curve. Through Monte Carlo simulation experiments and applications to the Breast Cosmesis and Diabetic Retinopathy datasets, we compare model performance using bias, empirical variance, estimated variance, and 95% coverage probability. We also evaluate two bootstrap confidence interval methods, the bias-corrected and accelerated (BCa) bootstrap and the Wald bootstrap, across the survival, log-survival, and complementary log–log scales. Results show that while both models provide reasonable regression coefficient inference, the Weibull AFT model consistently yields lower empirical variance for baseline survival estimation when the Weibull assumption holds. The complementary log–log scale provides the most stable coverage overall. These findings support the Weibull AFT model when its distributional assumption is plausible.
- Open Access
- 11 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (16) , 2478
Life-Stage Differences in the Longitudinal Associations of Multimorbidity Profiles with Economic Burden, Health-Related Quality of Life, and Inpatient Utilization
Background/Objectives: Multimorbidity is associated with substantial healthcare burdens, but its associations with health and economic outcomes among young adults remain poorly characterized. This study examined associations between clinically defined multimorbidity profiles and expenditures, catastrophic healthcare expenditure, health-related quality of life, and inpatient utilization across adult life stages. Methods: Medical Expenditure Panel Survey Panel 24 data were analyzed for 4331 U.S. adults followed from 2019 through 2022, including 942 young adults. Respondents were classified into five profiles: no included conditions, respiratory only, cardiometabolic only, any-cancer involved, and cardiorespiratory. Longitudinally weighted generalized estimating equations were fitted. Results: Profile distribution differed significantly across age groups. Among young adults, overall profile and profile-by-year tests were nonsignificant for total expenditures and most other outcomes. In 2019, the cardiorespiratory profile was associated with higher expected expenditures than no included conditions (expenditure ratio = 3.44, 95% CI: 1.59–7.46; p = 0.002). It was also associated with higher hospitalization odds across 2019–2022 (OR = 3.39, 95% CI: 1.28–8.99; p = 0.014), although the overall profile test was nonsignificant. Sex, insurance, and income were associated with several outcomes. Mental health scores were lower in 2021 and 2022 than in 2019 within the reference profile, without evidence of uniform changes across profiles. Conclusions: Overall profile effects were not consistently demonstrated among young adults. Parameter-specific cardiorespiratory estimates suggested a potentially elevated burden but remained exploratory because of sparse observations and nonsignificant overall tests. Socioeconomic vulnerability remained an important correlate of healthcare burden.
- 11 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (16) , 2478
Open AccessLife-Stage Differences in the Longitudinal Associations of Multimorbidity Profiles with Economic Burden, Health-Related Quality of Life, and Inpatient Utilization
Background/Objectives: Multimorbidity is associated with substantial healthcare burdens, but its associations with health and economic outcomes among young adults remain poorly characterized. This study examined associations between clinically defined multimorbidity profiles and expenditures, catastrophic healthcare expenditure, health-related quality of life, and inpatient utilization across adult life stages. Methods: Medical Expenditure Panel Survey Panel 24 data were analyzed for 4331 U.S. adults followed from 2019 through 2022, including 942 young adults. Respondents were classified into five profiles: no included conditions, respiratory only, cardiometabolic only, any-cancer involved, and cardiorespiratory. Longitudinally weighted generalized estimating equations were fitted. Results: Profile distribution differed significantly across age groups. Among young adults, overall profile and profile-by-year tests were nonsignificant for total expenditures and most other outcomes. In 2019, the cardiorespiratory profile was associated with higher expected expenditures than no included conditions (expenditure ratio = 3.44, 95% CI: 1.59–7.46; p = 0.002). It was also associated with higher hospitalization odds across 2019–2022 (OR = 3.39, 95% CI: 1.28–8.99; p = 0.014), although the overall profile test was nonsignificant. Sex, insurance, and income were associated with several outcomes. Mental health scores were lower in 2021 and 2022 than in 2019 within the reference profile, without evidence of uniform changes across profiles. Conclusions: Overall profile effects were not consistently demonstrated among young adults. Parameter-specific cardiorespiratory estimates suggested a potentially elevated burden but remained exploratory because of sparse observations and nonsignificant overall tests. Socioeconomic vulnerability remained an important correlate of healthcare burden.
- Open Access
- 29 May 2026
- Published by MDPI AG in Preprints.org
Long COVID as a Predictor of Incident Multimorbidity Among U.S. Civilians- Nationally Representative Evidence on Risk, and Downstream Burden
Long COVID has been associated with elevated risks of individual chronic conditions, but its role in the transition to multimorbidity remains unclear. We analyzed MEPS Panel 24 (2019-2022) data from 4,364 adults free of multimorbidity at baseline. COVID-19 exposure was classified as Long COVID, COVID-recovered, or no COVID. Discrete-time survival models estimated incident multimorbidity risk, and generalized estimating equations assessed healthcare expenditures, health-related quality of life, and inpatient utilization. Long COVID was associated with a 2.54-fold higher hazard of incident multimorbidity compared with no COVID (HR = 2.54; 95% CI: 1.26-5.10), while COVID-recovered participants also had elevated hazard (HR = 1.85; 95% CI: 1.08-3.17). Incident multimorbidity onset was associated with lower physical HRQoL, increased inpatient utilization, and higher healthcare expenditures. Long COVID was independently associated with lower mental HRQoL, while evidence for Long COVID-specific expenditure growth was model-dependent. These findings suggest that Long COVID and resolved COVID-19 infection may increase the risk of transitioning into multimorbidity, supporting integrated chronic disease surveillance, mental health assessment, and coordinated post-COVID care.
- 29 May 2026
- Published by MDPI AG in Preprints.org
Open AccessLong COVID as a Predictor of Incident Multimorbidity Among U.S. Civilians- Nationally Representative Evidence on Risk, and Downstream Burden
Long COVID has been associated with elevated risks of individual chronic conditions, but its role in the transition to multimorbidity remains unclear. We analyzed MEPS Panel 24 (2019-2022) data from 4,364 adults free of multimorbidity at baseline. COVID-19 exposure was classified as Long COVID, COVID-recovered, or no COVID. Discrete-time survival models estimated incident multimorbidity risk, and generalized estimating equations assessed healthcare expenditures, health-related quality of life, and inpatient utilization. Long COVID was associated with a 2.54-fold higher hazard of incident multimorbidity compared with no COVID (HR = 2.54; 95% CI: 1.26-5.10), while COVID-recovered participants also had elevated hazard (HR = 1.85; 95% CI: 1.08-3.17). Incident multimorbidity onset was associated with lower physical HRQoL, increased inpatient utilization, and higher healthcare expenditures. Long COVID was independently associated with lower mental HRQoL, while evidence for Long COVID-specific expenditure growth was model-dependent. These findings suggest that Long COVID and resolved COVID-19 infection may increase the risk of transitioning into multimorbidity, supporting integrated chronic disease surveillance, mental health assessment, and coordinated post-COVID care.
- Open Access
- 16 December 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (12) , 1870
Economic and Humanistic Burden of Multimorbidity in the United States: A Longitudinal Study of Expenditure and Quality of Life Trajectories, 2019–2022
This study examines the economic and humanistic burden associated with multimorbidity among adults in the United States. Using data from the 2019–2022 Medical Expenditure Panel Survey (MEPS), we identified individuals with two or more chronic conditions and assessed trends in healthcare expenditures, out-of-pocket costs, inpatient stays, and health-related quality of life (HRQL). Weighted analyses were conducted to estimate national patterns and annual changes across survey years. Outcomes were analyzed using generalized estimating equation (GEE) models with AR(1) working correlation to compare adjusted mean total and out-of-pocket expenditures, inpatient utilization, and mental and physical HRQL across multimorbidity profiles while controlling for sociodemographic and health factors. Findings showed that multimorbidity was associated with substantial economic burden, reflected in higher healthcare costs and out-of-pocket spending over time. HRQL consistently declined throughout the study years, highlighting the growing humanistic toll of chronic disease clustering. These findings provide longitudinal evidence of persistent disparities associated with multimorbidity and may inform future research and health system planning strategies. The results provide timely evidence for health policymakers and practitioners seeking to improve health system efficiency and equity in managing multimorbidity.
- 16 December 2025
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 22 (12) , 1870
Open AccessEconomic and Humanistic Burden of Multimorbidity in the United States: A Longitudinal Study of Expenditure and Quality of Life Trajectories, 2019–2022
This study examines the economic and humanistic burden associated with multimorbidity among adults in the United States. Using data from the 2019–2022 Medical Expenditure Panel Survey (MEPS), we identified individuals with two or more chronic conditions and assessed trends in healthcare expenditures, out-of-pocket costs, inpatient stays, and health-related quality of life (HRQL). Weighted analyses were conducted to estimate national patterns and annual changes across survey years. Outcomes were analyzed using generalized estimating equation (GEE) models with AR(1) working correlation to compare adjusted mean total and out-of-pocket expenditures, inpatient utilization, and mental and physical HRQL across multimorbidity profiles while controlling for sociodemographic and health factors. Findings showed that multimorbidity was associated with substantial economic burden, reflected in higher healthcare costs and out-of-pocket spending over time. HRQL consistently declined throughout the study years, highlighting the growing humanistic toll of chronic disease clustering. These findings provide longitudinal evidence of persistent disparities associated with multimorbidity and may inform future research and health system planning strategies. The results provide timely evidence for health policymakers and practitioners seeking to improve health system efficiency and equity in managing multimorbidity.
- Open Access
- 30 October 2025
- Published by MDPI AG in Preprints.org
Economic and Humanistic Burden of Multimorbidity in the United States: A Longitudinal Study of Expenditure and Quality of Life Trajectories, 2019–2022
This study examines the economic and humanistic burden associated with multimorbidity among adults in the United States. Using data from the 2019–2022 Medical Expenditure Panel Survey (MEPS), we identified individuals with two or more chronic conditions and assessed trends in health care expenditures, out-of-pocket costs, inpatient stays, and health-related quality of life (HRQL). Weighted analyses were conducted to estimate national patterns and annual changes across survey years. Mean adjusted total and out-of-pocket expenditures, inpatient visits, and mental HRQL scores were compared using regression models controlling for sociodemographic and health factors. Findings showed that multimorbidity was associated with substantial economic burden, reflected in higher healthcare costs and out-of-pocket spending over time. HRQL consistently declined across the study years, highlighting the growing humanistic toll of chronic disease clustering. These patterns underscore the need for policies that promote integrated care models, chronic disease prevention, and financial protection strategies for adults with multiple conditions. The results provide timely evidence for health policymakers and practitioners seeking to improve health system efficiency and equity in managing multimorbidity.
- 30 October 2025
- Published by MDPI AG in Preprints.org
Open AccessEconomic and Humanistic Burden of Multimorbidity in the United States: A Longitudinal Study of Expenditure and Quality of Life Trajectories, 2019–2022
This study examines the economic and humanistic burden associated with multimorbidity among adults in the United States. Using data from the 2019–2022 Medical Expenditure Panel Survey (MEPS), we identified individuals with two or more chronic conditions and assessed trends in health care expenditures, out-of-pocket costs, inpatient stays, and health-related quality of life (HRQL). Weighted analyses were conducted to estimate national patterns and annual changes across survey years. Mean adjusted total and out-of-pocket expenditures, inpatient visits, and mental HRQL scores were compared using regression models controlling for sociodemographic and health factors. Findings showed that multimorbidity was associated with substantial economic burden, reflected in higher healthcare costs and out-of-pocket spending over time. HRQL consistently declined across the study years, highlighting the growing humanistic toll of chronic disease clustering. These patterns underscore the need for policies that promote integrated care models, chronic disease prevention, and financial protection strategies for adults with multiple conditions. The results provide timely evidence for health policymakers and practitioners seeking to improve health system efficiency and equity in managing multimorbidity.